Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04232436
Other study ID # RECHMPL20_0035
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2019
Est. completion date March 1, 2020

Study information

Verified date January 2020
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The incidence of twin pregnancies has increased and currently accounts for 1.8% of all deliveries. 47.5% of twins are born prematurely (vs. 6% for singletons) of which 9.9% before 32SA. Caesarean section rates are also higher than for singletons (53.7% vs 19.2%) and 31.8% of caesarean sections are performed before delivery.

The optimal mode of delivery for preterm twins remains controversial. The latest recommendations for clinical practice emphasize that it is not appropriate to recommend one mode of delivery rather than another in the case of twin pregnancies at any term.

In view of all these elements, we wished to carry out a retrospective study at the Montpellier University Hospital in order to compare the neonatal outcome of preterms twins according to their mode of delivery : planned vaginal delivery versus planned cesarean delivery.


Recruitment information / eligibility

Status Completed
Enrollment 204
Est. completion date March 1, 2020
Est. primary completion date July 30, 2019
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion criteria:

- twins born at Montpellier University Hospital

- between 24SA and 32SA+6

- January 2010 to July 2019

- The mothers must have gone into labour spontaneously or after preterm rupture of membranes

- first twin in cephalic presentation

Exclusion criteria:

- twin to twin transfusion syndrome

- monoamniotic pregnancies

- cause of delivery other than preterm labor or preterm rupture of membranes

- lethal malformation

- first twin in breech or transverse presentation

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survival at discharge
Survival at discharge
Survival without severe morbidity
Survival without severe morbidity (IVH, severe BPD, NEC, ROP)

Locations

Country Name City State
France Uhmontpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary survival at discharge and survival survival at discharge and survival without severe morbidity during neonatal hospitalization
Secondary survival at 2 years of corrected survival at 2 years of corrected during the first two years corrected age
Secondary age without neurosensory impairment age without neurosensory impairment during the first two years corrected age
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04588597 - Obstetric and Neonatal Outcomes of Twin Pregnancy
Recruiting NCT04051567 - Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies Phase 4
Terminated NCT03863613 - Pessary Versus Cerclage With or Without Progesterone in Twins N/A
Completed NCT00502190 - Evaluation Of Pessaries In Twin Pregnancies With A Short Cervix (25 mm) Between 20-28 WG (EPEGE) Phase 3
Completed NCT04353856 - Quality of Life During a Twin Pregnancy
Recruiting NCT05727085 - Cohort of Twin Pregnancy and the Offspring
Completed NCT05104255 - Neonatal Outcomes in Twin Pregnancies
Completed NCT00187369 - The Twin Birth Study: A Trial Comparing Planned Vaginal Birth to Elective Caesarean Section of Twins N/A
Withdrawn NCT03540225 - Vaginal Progesterone for the Prevention of Preterm Birth in Twins Phase 3